arrow
B

Barbara Nasiłowska-Adamska

Institute of Hematology and Transfusion Medicine
H指数:10
被引数:361

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multicenter retrospective analysis by the Polish Adult Leukemia Group on tuberculosis occurrence and outcomes after hematopoietic cell transplantation

波兰成人白血病组关于造血细胞移植后结核病发生和结局的多中心回顾性分析

2026-05-110
OAAI
miR-302d-3p expression and genotype are associated with CMV replication after allogeneic haematopoietic stem cell transplantation

miR-302d-3p的表达和基因型与异基因造血干细胞移植后的CMV复制相关

2025-10-080
OAAI
ILT-2 and ILT-4 expression and donor genotype as factors associated with HSCT outcome

ILT-2和ILT-4的表达以及供者基因型作为与HSCT结局相关的因素

2025-10-020
PRE
Soluble MICA concentrations and genetic variability of MICA and its NKG2D receptor as factors affecting Graft-versus-Host Disease development after allogeneic haematopoietic stem cell transplantation

可溶性MICA浓度和MICA及其NKG2D受体的遗传变异性是异基因造血干细胞移植后移植物抗宿主病发展的影响因素

2024-11-010
OAAI
Significance of HLA-E and its two NKG2 receptors in development of complications after allogeneic transplantation of hematopoietic stem cells

Hla-e及其两种NKG2受体在异基因造血干细胞移植后并发症发生中的意义

2023-10-132
OAAI
HLA-inferred extended haplotype disparity level is more relevant than the level of HLA mismatch alone for the patients survival and GvHD in T cell-replate hematopoietic stem cell transplantation from unrelated donor
2018-06-0111
PREAI
Donor NK cell licensing in control of malignancy in hematopoietic stem cell transplant recipients
2014-08-2723
PREAI
Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis

自体干细胞移植巩固治疗首次缓解期外周T细胞淋巴瘤的远期疗效及危险因素分析

2013-03-087
OAAI